PBM

Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

To drive down costs, insurers are delivering high-priced infusion drugs via third-party pharmacies. Hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."

Drug-makers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Florida has already taken action. Now, Congress is finally on board, too, but will it matter?

The governor moved quickly to sign a bill that will place restrictions on pharmacy benefit managers. The House and Senate unanimously passed the measure Tuesday.

The Senate Health Policy Committee approved the bill, while the House Healthcare Regulation Subcommittee is slated to take up its version on Tuesday.

A Tampa lawmaker is hoping to lower drug prices and improve care for Floridians by regulating companies that serve as middlemen in the health care...